Aims Excessively acidic urine is the dominant factor in uric acid stone formation. Recent evidence implicating insulin resistance has revived interest in its causation. We reviewed data on uric acid stone formers attending a general stones clinic to find out whether this supports and adds to current concepts. Methods A retrospective database study of 1504 stone formers investigated at the Southampton renal stones clinic from 1990 to March 2007. Uric acid stone formers and idiopathic calcium stone formers were compared using non-parametric tests. Results Fifty-nine patients (3.9%; 43 men) had uric acid stones. In men the commonest associated conditions were diabetes (20%), gout (20%) and an ileostomy (15%); in women, diabetes (33%), urinary infections (27%) and hyperparathyroidism (20%). Most patients with diabetes (85% of men, 75% of women), however, produced calcium stones. Risk factors did not differ significantly between calcium and uric acid stone formers with diabetes, gout or ileostomies. The median urine pH of men with idiopathic calcium stones was 6.20, idiopathic uric acid stones 5.47, diabetes 5.68, gout 6.05, diabetes and gout 5.20 and ileostomy 5.10. Plasma urate was higher with gout and idiopathic uric acid stones. Urate excretion was increased in gout. Oxalate excretion was lower with idiopathic uric acid stones (new finding). Urine volume decreased and oxalate concentration increased with ileostomy.
INTRODUCTION
Uric acid stones account for approximately 5-10% of all renal stones. Contrary to expectation, unless massive, hyperuricosuria does not appear to be a significant risk factor for uric acid stones. They are recognised to occur more commonly in abnormally acidic, concentrated urine. The explanation of the acidification defect in idiopathic uric acid stone formation is uncertain. Empirical treatment with alkali and hydration is normally effective and reduces stone recurrence. [1] [2] [3] [4] [5] Epidemiological and clinic data have demonstrated an association between uric acid stone formation and diabetes, glucose intolerance and obesity. 3 5-11 The evidence from clinical studies suggests this association may in part be related to insulin resistance. 7 12 Continuing work in relation to clinical observations and our expanding knowledge of molecular mechanisms underlying renal excretion of acid [13] [14] [15] should help to explain the mechanisms underlying uric acid stones.
We have reviewed risk factors for stones among patients assessed at our renal stones clinic from 1990 to March 2007 and reported the demographic and global biochemistry for this cohort of 2800 patients. 16 In this paper we have focused on the subgroup forming uric acid stones.
PATIENTS AND METHODS Stones clinic database
The stones clinic database, held on Microsoft Access (97-2003), was created in 1996 and includes data for most patients investigated for stones risk at their initial presentation to the Renal Stones Clinic of the Clinical Biochemistry Department of Southampton University Hospitals from June 1990 to March 2007. 16 The data were anonymised for the research study which was approved by the Regional Ethics Committee.
Patients and samples
The database holds data on 1983 male and 816 female stone formers. The stone composition was recorded for 1090 (55%) of the men and for 414 (51%) of the women. The cases for this study were the uric acid stone formers. Clinical factors which increased the risk for stones were recorded from the patients' histories, referral letters, imaging reports and diagnostic tests from other clinics. Idiopathic stone formers had no underlying disorder associated with hyperuricosaemia (haematological or lymphoproliferative disorders or psoriasis) or with stones (renal tract anomalies, recurrent urinary infections, intestinal resection, primary hyperparathyroidism or sarcoidosis). At the first clinic attendance, non-fasting blood was collected and a paired fresh random urine sample. Patients were instructed on how to collect a 24 h sample of urine at home. Upon receipt, the volume was determined from weight, an aliquot was removed for uric acid analysis, and the remaining urine was acidified to a pH 2.00. 16 
Biochemical analyses
All samples were analysed by the Clinical Chemistry Department at Southampton General Hospital using routine assays employing automated systems. The pH of the fresh random urine was measured with a glass electrode. Stones were analysed qualitatively, with chemical methods using a Merckognost urinary calculi analysis kit (Merck, Darmstadt, Germany). All the assays performed well in external quality assessment schemes. 16 The standard analyses for 24 h urine collections were creatinine, calcium and oxalate. Urate and citrate were added variably, often for patients with more severe stone problems or with associated medical disorders. Twenty-four hour urine data were rejected if there was no recorded creatinine value or if the creatinine was low (men: creatinine<10.60 mmol/24 h; women<7.00 mmol/24 h), to avoid incomplete 24 h collections. 17 Renal threshold of phosphate concentration was calculated from phosphate and creatinine concentrations of paired plasma and random urine samples. 16 Urate clearance (l/24 h) was calculated as urate (mmol/24 h)/plasma urate (mmol/l) and fractional urate excretion (FEUA) (%) as urate clearance l/24 h/creatinine clearance l/24 h×100.
Plasma and urine urate results of patients taking allopurinol or losartan, with haematological or lymphoproliferative disorders, or psoriasis were excluded from comparisons. 
RESULTS
Of 1090 men with known stone composition, 43 (4%) produced uric acid stones (17 uric acid; 26 mixed uric acid/ calcium oxalate) and 1039 (95%) produced calcium-containing stones. Among 414 women, 16 (4%) had uric acid stones (6 uric acid; 10 mixed) and 391 (94%) had calcium-containing stones. Table 1 shows the frequency of underlying conditions thought to predispose to uric acid stone formation. Nine patients had more than one predisposing disorder. In men, the largest single group (35%) were idiopathic uric acid stone formers; 28% had gout or diabetes (all non-insulin dependent, NIDDM) and 14% had an ileostomy. Five (33%) of women with a recorded diagnosis had diabetes, four with non-insulin dependent diabetes and one with insulin dependency.
Risk factors for uric acid stone formation Global findings
In order to find out why stone formers produce uric acid stones and not the more common calcium stones, risk factors for the uric acid stone formers were compared with idiopathic calcium stone formers (138 women; 465 men) (figure 1). The striking difference was in urine pH which was significantly lower in uric acid stone formers, with values below 5.50 in 80% of women and 54% of men. There was also a small decrease in plasma bicarbonate. Plasma urate was higher but globally 24 h urinary urate excretion was not increased. Plasma calcium, phosphate, urinary volume, urate clearance, citrate excretion and FEUA were similar to idiopathic calcium stone formers. Calcium excretion was lower.
Findings for clinical subgroups of men with uric acid stones
We segregated the men with uric acid stones according to associated clinical disorders. We compared their data with calcium stone formers with the same conditions identified from the full cohort of men on the database. For each category, the total number of men (number with uric acid stones) was: gout 31 (3), diabetes 53 (8), ileostomy 10 (6) and idiopathic stone formers 480 (15) . It was notable that uric acid stones were produced by only a minority of men with gout (10%) or diabetes (15%). The incidence was higher (40%) in 10 men with diabetes and gout than in 43 with diabetes only (9%). Statistically significant differences were observed only between men with idiopathic uric acid and calcium stones (figure 2), perhaps partly explained by the small numbers of uric acid stone formers in other groups. Five (25%) of the 20 women with diabetes produced uric acid stones. Risk factors for stone formation in gout, diabetes and ileostomies and in idiopathic uric acid stone formers
In order to look for differences in stones risk factors associated with gout, diabetes and ileostomies, data for uric acid and calcium stone formers within these clinical groups were combined (figure 3). Patients with diabetes, with and without gout were segregated. Compared with idiopathic calcium stone formers the key findings were: -Gout: Urine pH was lower, but not significantly. Urate excretion was increased and exceeded the upper reference limit in around half of the men and plasma urate was increased. Urine calcium was lower. No other significant differences were observed for plasma bicarbonate, urate clearance, FEUA or citrate (analysed on few urine samples).
DISCUSSION
This was a retrospective study of historical data from a renal stone clinic. Inevitably, the data were incomplete, but the number of patients was large enough to draw useful conclusions.
The incidence of uric acid stone formers was lower than previously reported and was not higher in men. This probably reflects local referral practices. As in other cohorts, uric acid stone formers were older than calcium stone formers, and men most often had idiopathic stones. 1 2 4 8 10 The frequency of diabetes was comparable with reports of around 30-40% and 5-12%, respectively, 6 8 9 11 and of ileostomy of 50-70%. 2 18 There is therefore clearly an increased risk for uric acid stones associated with these disorders. Despite this, the majority of men with diabetes and gout in this cohort produced calcium stones, as reported.
8 Figure 3 Plasma and urine variants of men with gout (n=31), diabetes (dm; n=43), diabetes and gout (n=10) and ileostomy (n=10) compared with idiopathic calcium stone formers (idiop ca; n=465). For these comparisons, the data for uric acid and calcium stone formers were combined. Data for 15 idiopathic uric acid (idiop ua) stone formers were also compared. Medians, IQRs, minimum and maximum values are presented, with p values for statistically significant differences from idiopathic calcium stone formers ( p<0.05; Mann-Whitney U test).
Globally, the striking difference between uric acid and idiopathic calcium stone formers was a low urinary pH. This is accepted as the dominant risk factor for uric acid stone formation. [1] [2] [3] [4] [5] Urate excretion and the frequency of hyperuricosuria were not increased. After segregating men with gout, diabetes, ileostomies and idiopathic stones, the only men in whom risk factors differed significantly between uric acid and calcium stone formers were those with idiopathic stones. Differences in the other groups may have been masked by the small numbers of uric acid stone formers. Additionally, urine chemistries may have changed from those prevailing when the stones formed.
There is frequently no apparent cause for an excessively low urine pH in uric acid stone formers and the explanation remains speculative. Falling urine pH with age 16 19-21 and a high dietary acid load 7 9 11 are contributory. Metabolic studies demonstrated that idiopathic uric acid stone formers are insulin resistant and have an inappropriately low ammonium excretion for their urinary acidity. 12 22 Normally ammonia buffers around 50-70% of basal net acid excretion and more in metabolic acidosis. Ammonium ions released from glutamine by glutaminase in the proximal renal tubule are secreted into the tubular lumen by the Na + /H + transporter (NHE3), largely transferred into the medullary interstitium, concentrated and ultimately secreted (as ammonia) back into the collecting ducts to buffer H + . 15 Since insulin stimulates glutaminase 23 and NHE3, 13 14 24 impaired insulin bioactivity in the kidney might reduce these activities. 11 12 22 However the kidney is not an insulin-resistant organ and the abnormalities may result instead from chronic exposure to increased circulating insulin. 25 26 Insulin increases activity of several renal tubular transporters 24 and promotes uric acid absorption. 25 27 28 Renal steatosis may be implicated. 29 The idiopathic uric acid stone formers in this study had a high plasma urate, but this was not associated with enhanced renal urate absorption (reduced FEUA).
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Although urate results of men taking allopurinol and losartan were excluded, other medications which modify urate excretion 31 may have clouded the issue. The significant reduction of oxalate excretion is a new observation. This merits exploration since renal oxalate, urate and sulfate transport are interlinked. 31 32 Uric acid stones and low urine pH are increased in other disorders with insulin resistance. 3 5-11 Although it has been assumed that impaired ammonium production may be responsible, this has not been demonstrated so far in clinical studies. Evidence indicates that insulin resistance alone does not account for excessive urine acidity in diabetes. 7 30 33 Because of the small numbers of patients with uric acid stones, data for uric acid and calcium stone formers were combined in order to examine stone risk factors separately for patients with gout, diabetes and ileostomies. Using idiopathic calcium stone formers as a common comparator, there were differences. Men with gout had increased plasma and 24 h urine urate levels but urinary pH, although lower, was not reduced significantly. Urate levels of men with diabetes, in contrast, were not increased, but urine pH was reduced significantly, particularly in those who also had gout. This might indicate that different processes causing urine acidity in gout and diabetes are additive when combined. The urine of patients with an ileostomy was highly acidic, of low volume and had a high oxalate concentration due to chronically high losses of intestinal fluid with pH around 7.0. 18 34 Take-home messages ▸ Most uric acid stone formers produce acidic urine. ▸ The incidence of uric acid stones is increased in type 2 diabetes, but most patients with diabetes make calcium stones. ▸ Different mechanisms may account for low pH in diabetes, gout and idiopathic uric acid stone formers. ▸ Future studies should address diabetes control and ammonium, amino acid and phosphate excretion. ▸ Reduced oxalate excretion in idiopathic uric acid stone formers is a new observation. This should be explored in cohorts with non-stone forming controls. ▸ The link between urine acidification and insulin resistance needs clarification.
What the paper adds ▸ It adds to the evidence of increased incidence of uric acid stones in diabetes, but confirms that most patients with diabetes make calcium stones. ▸ The disorders commonly associated with uric acid stone formation are to some extent sex-dependent. ▸ It demonstrates differences between male stone formers with diabetes, gout and idiopathic uric acid stones which suggest that different mechanisms may be involved in urine hyperacidity. ▸ It demonstrated reduced oxalate excretion in men with idiopathic uric acid stones which, if confirmed, may give insight into renal transporter activities in this disorder. ▸ It highlights the need to consider the impact of hyperinsulinism on renal tubular transport in insulin resistance.
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